A pair of studies published in Diabetologia demonstrate that use of continuous glucose monitors (CGMs) reduces ...

Rznomics Inc. scored a potential ₩1.9 trillion (US$1.35 billion) global license option agreement with Eli Lilly and Co. to ...

Metabolic disorders such as argininosuccinic and glutaric aciduria, methylmalonic acidemia, homocystinuria or primary hyperoxaluria require specific diets to prevent the accumulation of substances ...

A study published in Molecular Therapy has presented a promising gene therapy approach for treating centronuclear myopathy.

The U.S. Centers for Medicare & Medicaid Services reported a request for information for a modernized digital health ...

Current therapies for chronic hepatitis B virus (HBV) infection can effectively suppress viral replication but do not achieve ...

Pillai Universal LLC has disclosed compounds reported to be useful for the treatment of metastatic cancer.

Quantx Biosciences Ltd. has presented data on their novel DNA polymerase θ (POLQ) inhibitor QX-001280 for treating cancer.

Esophageal cancer accounts for the sixth leading cause of cancer-related deaths worldwide. The clinical efficacy of therapies for esophageal squamous-cell carcinoma (ESCC) remain limited due to drug ...

Just two months after Inozyme Pharma Inc. cut its workforce by 25% and prioritized activities to focus on a BLA filing for INZ-701 for ENPP1 deficiency, interim phase III data from its Energy 3 trial ...

Royal Philips NV unveiled its Future Health Index report for 2025, and it reveals the widening trust gap between health care professionals and patients concerning the adoption of AI in health care.

Recognizing the potential legal challenges to U.S. President Donald Trump’s executive order calling for most-favored-nation (MFN) prescription drug pricing and the limits of that order, several ...